Strengths

Berry’s scale in consumer and healthcare packaging supports procurement leverage and customer reach, but peers with broader global footprints still hold stronger diversification.

ROIC of 5.8% indicates the business still earns returns above a distressed profile, yet it trails higher-quality packaging peers with more durable capital efficiency.

A 42.8-day cash conversion cycle shows working-capital discipline is adequate for the sector, although best-in-class peers typically convert cash faster.

The company’s established relationships with large branded customers create switching friction, which supports recurring demand more than smaller regional competitors.

Weaknesses

Net debt to EBITDA of 4.4x leaves Berry more leveraged than many packaging peers, constraining flexibility and increasing sensitivity to margin pressure.

Debt-to-equity of 2.45x signals a heavier balance-sheet burden than stronger peers, which typically preserve more room for reinvestment and acquisitions.

Current ratio of 1.25 and quick ratio of 0.80 indicate limited liquidity headroom, leaving the company less resilient than peers with stronger near-term coverage.

The modest ROIC profile suggests capital intensity still absorbs returns, making Berry structurally less efficient than higher-margin packaging competitors.

Opportunities

Berry can improve structural positioning by passing through resin and energy costs more effectively, which would narrow the margin gap versus better-priced peers.

Portfolio simplification and mix shift toward higher-value healthcare and specialty packaging could lift returns, as peers with more focused exposure often earn superior margins.

Further working-capital optimization could reduce cash tied up in operations, improving free-cash-flow conversion relative to slower-moving competitors.

Debt reduction would strengthen strategic flexibility and lower financing drag, allowing Berry to compete more effectively against less levered peers.

Threats

Highly leveraged peers and private-label competition can pressure pricing, because Berry has less balance-sheet room to absorb prolonged margin compression.

Customer concentration in large packaged-goods and healthcare accounts increases bargaining pressure, which can erode pricing power versus more diversified peers.

Input-cost volatility in resin, energy, and freight can compress returns when pass-through timing lags, leaving Berry more exposed than stronger-margin competitors.

A slower deleveraging path could keep financing costs elevated, limiting reinvestment capacity and weakening competitive positioning over the next several years.

Overall Score

Berry’s scale and customer relationships provide some structural support, but elevated leverage and only modest capital efficiency leave it weaker than stronger packaging peers.